Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

NARecruitingINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

June 30, 2029

Study Completion Date

December 31, 2029

Conditions
Intracranial HemorrhagesAtrial Fibrillation (AF)Atrial Flutter
Interventions
DEVICE

Percutaneous closure of the LAA (Watchman / Watchman FLX)

LAA closure procedure will be done by experienced operators according to the local SOP. LAA closure will be performed under fluoroscopic and TEE guidance within conscious sedation or general anesthesia. Antibiotic single-shot prophylaxis should be administered peri-procedurally (i.e., cefazolin 2 g). The specific anatomy of the LAA is evaluated and an appropriately sized CE-marked device (Watchman or Watchman FLX) is deployed. LAA angiography and TEE imaging is performed to identify optimal positioning of the device and to exclude a relevant leak. Following device deployment, patients will receive a therapy according to the manufacturers IFU, currently Aspirin and clopidogrel for 3 months followed by single Aspirin up to 12 months. Alternatively, 3 months of NOAC followed by Aspirin monotherapy up to 12 months are possible.

Trial Locations (33)

12203

RECRUITING

Charité - Universitätsmedizin Berlin (CBF), Berlin

13353

ACTIVE_NOT_RECRUITING

Charité - Universitätsmedizin Berlin (CVK, Berlin

22041

RECRUITING

Cardiologicum Hamburg, Hamburg

22043

RECRUITING

Asklepios Klinik Wandsbek, Hamburg

22417

RECRUITING

Asklepios Klinik Nord Heidberg, Hamburg

22763

RECRUITING

Asklepios Klinik Altona, Hamburg

23538

RECRUITING

Universitätsklinikum Schleswig-Holstein (UKSH), Lübeck

33617

RECRUITING

Evangelisches Klinikum Bethel, Bielefeld

44137

ACTIVE_NOT_RECRUITING

Herz-Kreislauf-Zentrum, Rotenburg an der Fulda

ACTIVE_NOT_RECRUITING

Klinikum Dortmund, Dortmund

44309

RECRUITING

Knappschaft Kliniken, Dortmund

56073

RECRUITING

Katholisches Klinikum Koblenz • Montabaur, Koblenz

67655

RECRUITING

Westpfalz-Klinikum, Kaiserslautern

68167

RECRUITING

University Hospital Mannheim, Mannheim

RECRUITING

University Hospital Magdeburg, Magdeburg

83022

ACTIVE_NOT_RECRUITING

RoMed Klinikum, Rosenheim

85049

RECRUITING

Klinikum Ingolstadt, Ingolstadt

89331

ACTIVE_NOT_RECRUITING

Therapiezentrum Burgau, Burgau

91054

RECRUITING

Universitätsklinikum Erlangen, Erlangen

96450

RECRUITING

REGIOMED Klinikum Coburg, Coburg

97616

ACTIVE_NOT_RECRUITING

RHÖN-KLINIKUM Campus Bad Neustadt, Bad Neustadt an der Saale

99089

RECRUITING

Helios Klinikum Erfurt, Erfurt

09113

RECRUITING

Klinikum Chemnitz, Chemnitz

01307

RECRUITING

Dresden Heart Center, Dresden

04103

RECRUITING

University Hospital Leipzig, Leipzig

04129

RECRUITING

Klinikum St. Georg, Leipzig

04289

RECRUITING

Heart Center Leipzig, Leipzig

01796

RECRUITING

Helios Klinikum Pirna, Pirna

08060

RECRUITING

Heinrich-Braun-Klinikum (HBK), Zwickau

07747

RECRUITING

University Hospital Jena, Jena

61-848

NOT_YET_RECRUITING

Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan

43-316

NOT_YET_RECRUITING

Polsko-Amerykańskie Kliniki Serca, Bielsko-Biala

40-635

RECRUITING

Górnośląskim Centrum Medycznym, Katowice

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

KCRI

OTHER

lead

Jena University Hospital

OTHER

NCT04298723 - Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. | Biotech Hunter | Biotech Hunter